Efficacy of Liraglutide in Non-Diabetic Obese Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Joshuan J BarbozaMariella R HuamánBeatriz MelgarCarlos Diaz-ArocutipaGermán Valenzuela-RodríguezAdrian V HernándezPublished in: Journal of clinical medicine (2022)
In non-diabetic obese adults, liraglutide reduced body weight, BMI and blood pressure in comparison to placebo. Adverse events, Hb1Ac levels and hypoglycemic episodes were not different than placebo.
Keyphrases
- body weight
- type diabetes
- blood pressure
- adipose tissue
- weight loss
- metabolic syndrome
- wound healing
- systematic review
- double blind
- obese patients
- phase iii
- bariatric surgery
- insulin resistance
- physical activity
- hypertensive patients
- randomized controlled trial
- weight gain
- blood glucose
- glycemic control
- open label
- skeletal muscle
- clinical evaluation